ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Cross Below 50 Day Moving Average – Here’s What Happened

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) crossed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $112.68 and traded as low as $101.11. ProShares Ultra Nasdaq Biotechnology shares last traded at $105.06, with a volume of 10,901 shares traded.

ProShares Ultra Nasdaq Biotechnology Price Performance

The business has a 50-day moving average of $112.97 and a two-hundred day moving average of $96.68. The company has a market cap of $93.25 million, a P/E ratio of 20.68 and a beta of 1.20.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

A hedge fund recently raised its position in ProShares Ultra Nasdaq Biotechnology stock. Kaizen Financial Strategies lifted its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 4.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,565 shares of the exchange traded fund’s stock after buying an additional 250 shares during the period. Kaizen Financial Strategies owned approximately 0.60% of ProShares Ultra Nasdaq Biotechnology worth $483,000 as of its most recent SEC filing.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.